Urinary Bladder, Overactive
"Urinary Bladder, Overactive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Descriptor ID |
D053201
|
MeSH Number(s) |
C12.777.829.866 C13.351.968.829.813 C23.888.942.343.780
|
Concept/Terms |
Overactive Detrusor- Overactive Detrusor
- Detrusor, Overactive
- Overactive Detrusor Function
- Detrusor Function, Overactive
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder, Overactive".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder, Overactive".
This graph shows the total number of publications written about "Urinary Bladder, Overactive" by people in this website by year, and whether "Urinary Bladder, Overactive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 5 | 2 | 7 |
2018 | 9 | 0 | 9 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Urinary Bladder, Overactive" by people in Profiles.
-
Urogynecological survey in a group of Italian women treated for overactive bladder: Symptoms and quality of life analysis during the Covid-19 period. Taiwan J Obstet Gynecol. 2021 Jul; 60(4):674-678.
-
Is coronavirus disease 2019 associated with indicators of long-term bladder dysfunction? Neurourol Urodyn. 2021 06; 40(5):1200-1206.
-
Taking care of continence patients during the COVID-19 pandemic. Br J Nurs. 2020 Dec 10; 29(22):1318-1324.
-
Yonder: Long Covid, mental health video consultations, overactive bladder syndrome, and haematological malignancies. Br J Gen Pract. 2020 12; 70(701):601.
-
COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). Med Hypotheses. 2020 Dec; 145:110375.
-
Survey on prevalence of lower urinary tract symptoms in an Asian population. Hong Kong Med J. 2019 Feb; 25(1):13-20.
-
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. PLoS One. 2018; 13(9):e0204456.
-
The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States. J Occup Environ Med. 2018 09; 60(9):847-852.
-
Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder: A prospective, randomized controlled, crossover-design, pilot study. Medicine (Baltimore). 2018 Aug; 97(34):e12016.
-
Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. Neurourol Urodyn. 2018 06; 37(5):1693-1700.